Vibrio vulnificus biotype 3 multifunctional autoprocessing RTX toxin is an adenylate cyclase toxin essential for virulence in mice

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 2148-2157

  Ziolo, Kevin J ^a   Jeong, Hee Gon ^a,b   Kwak, Jayme S ^a,c   Yang, Shuangni ^a   Lavker, Robert M ^a   Satchell, Karla J F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Chungnam National University   (South Korea)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; BACTERIAL TOXIN; MULTIFUNCTIONAL AUTOPROCESSING RTX TOXIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADENYLATE CYCLASE ASSAY; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL CELL; BACTERIAL VIRULENCE; BIOTYPE; BORDETELLA PERTUSSIS; CHO CELL; CLIMATE CHANGE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; IN VITRO STUDY; ISRAEL; MOUSE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; SINGLE NUCLEOTIDE POLYMORPHISM; TILAPIA; TISSUE INJURY; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION; WOUND INFECTION;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CHO CELLS; CLONING, MOLECULAR; COCULTURE TECHNIQUES; CRICETINAE; CRICETULUS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; VIBRIO INFECTIONS; VIBRIO VULNIFICUS; VIRULENCE;

EID: 84898907292     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00017-14     Document Type: Article

References (55)

1. Jones MK, Oliver JD. 2009. Vibrio vulnificus: disease and pathogenesis. Infect. Immun. 77:1723-1733. http://dx.doi.org/10.1128/IAI.01046-08.
2. Oliver JD. 2005. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol. Infect. 133:383-391. http://dx.doi.org/10.1017/S0950268805003894.
3. Horseman MA, Surani S. 2011. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. Int. J. Infect. Dis. 15:e157-166. http://dx.doi.org/10.1016/j.ijid.2010.11.003.
4. Menon MP, Yu PA, Iwamoto M, Painter J. 2014. Pre-existing medical conditions associated with Vibrio vulnificus septicaemia. Epidemiol. Infect. 142:878-881. http://dx.doi.org/10.1017/S0950268813001593.
5. Dechet AM, Yu PA, Koram N, Painter J. 2008. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin. Infect. Dis. 46:970-976. http://dx.doi.org/10.1086/529148.
6. Baker-Austin C, Trinanes JA, Taylor NGH, Hartnell R, Siitonen A, Martinez-Urtaza. 2013. Emerging Vibrio risk at high latitudes in response to ocean warming. Nat. Clim. Chang. 3:73-77. (Letter.) http://dx.doi.org /10.1038/nclimate1628.
7. Paz S, Bisharat N, Paz E, Kidar O, Cohen D. 2007. Climate change and the emergence of Vibrio vulnificus disease in Israel. Environ. Res. 103:390-396. http://dx.doi.org/10.1016/j.envres.2006.07.002.
8. Dalsgaard A, Frimodt-Moller N, Bruun B, Hoi L, Larsen JL. 1996. Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur. J. Clin. Microbiol. Infect. Dis. 15:227-232. http://dx.doi.org/10.1007/BF01591359.
9. Frank C, Littman M, Alpers K, Hallauer J. 2006. Vibrio vulnificus wound infections after contact with the Baltic Sea, Germany. Euro Surveill. 11: E060817.1.
10. Veenstra J, Rietra PJ, Coster JM, Slaats E, Dirks-Go S. 1994. Seasonal variations in the occurrence of Vibrio vulnificus along the Dutch coast. Epidemiol. Infect. 112:285-290. http://dx.doi.org/10.1017/S09502688000 57691.
11. Torres L, Escobar S, Lopez AI, Marco ML, Pobo V. 2002. Wound infection due to Vibrio vulnificus in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 21:537-538. http://dx.doi.org/10.1007/s10096-002-0767-4.
12. Amaro C, Biosca EG. 1996. Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans. Appl. Environ. Microbiol. 62:1454-1457.
13. Tison DL, Nishibuchi M, Greenwood JD, Seidler RJ. 1982. Vibrio vulnificus biogroup 2: new biogroup pathogenic for eels. Appl. Environ. Microbiol. 44:640-646.
14. Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L, Soboh S, Colodner R, Cameron DN, Wykstra DL, Swerdlow DL, Farmer JJ, III. 1999. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group. Lancet 354:1421-1424. http://dx.doi.org/10.1016/S0140-6736(99)02471-X.
15. Zaidenstein R, Sadik C, Lerner L, Valinsky L, Kopelowitz J, Yishai R, Agmon V, Parsons M, Bopp C, Weinberger M. 2008. Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel. Emerg. Infect. Dis. 14:1875-1882. http://dx.doi.org/10.3201/eid1412.080499.
16. Jeong HG, Satchell KJ. 2012. Additive function of Vibrio vulnificus MARTXVv and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection. PLoS Pathog. 8:e1002581. http: //dx.doi.org/10.1371/journal.ppat.1002581.
17. Lo HR, Lin JH, Chen YH, Chen CL, Shao CP, Lai YC, Hor LI. 2011. RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis. J. Infect. Dis. 203:1866-1874. http://dx.doi.org/10.1093/infdis/jir070.
18. Lee CT, Pajuelo D, Llorens A, Chen YH, Leiro JM, Padros F, Hor LI, Amaro C. 2013. MARTX of Vibrio vulnificus biotype 2 is a virulence and survival factor. Environ. Microbiol. 15:419-432. http://dx.doi.org/10.1111/j.1462-2920.2012.02854.x.
19. Satchell KJ. 2011. Structure and function of MARTX toxins and other large repetitive RTX proteins. Annu. Rev. Microbiol. 65:71-90. http://dx.doi.org/10.1146/annurev-micro-090110-102943.
20. Egerer M, Satchell KJ. 2010. Inositol hexakisphosphate-induced autoprocessing of large bacterial protein toxins. PLoS Pathog. 6:e1000942. http://dx.doi.org/10.1371/journal.ppat.1000942.
21. Kwak JS, Jeong HG, Satchell KJ. 2011. Vibrio vulnificus rtxA1 gene recombination generates toxin variants with altered potency during intestinal infection. Proc. Natl. Acad. Sci. U. S. A. 108:1645-1650. http://dx.doi.org/10.1073/pnas.1014339108.
22. Roig FJ, Gonzalez-Candelas F, Amaro C. 2011. Domain organization and evolution of multifunctional autoprocessing repeats-in-toxin (MARTX) toxin in Vibrio vulnificus. Appl. Environ. Microbiol. 77:657-668. http://dx.doi.org/10.1128/AEM.01806-10.
23. Morrison SS, Williams T, Cain A, Froelich B, Taylor C, Baker-Austin C, Verner-Jeffreys D, Hartnell R, Oliver JD, Gibas CJ. 2012. Pyrosequencing-based comparative genome analysis of Vibrio vulnificus environmental isolates. PLoS One 7:e37553. http://dx.doi.org/10.1371/journal.pone.0037553.
24. Bisharat N, Cohen DI, Harding RM, Falush D, Crook DW, Peto T, Maiden MC. 2005. Hybrid Vibrio vulnificus. Emerg. Infect. Dis. 11:30-35. http://dx.doi.org/10.3201/eid1101.040440.
25. Jolley KA, Chan MS, Maiden MC. 2004. mlstdbNet-distributed multilocus sequence typing (MLST) databases. BMC Bioinformatics 5:86. http: //dx.doi.org/10.1186/1471-2105-5-86.
26. Philippe N, Alcaraz JP, Coursange E, Geiselmann J, Schneider D. 2004. Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid 51:246-255. http://dx.doi.org/10.1016/j.plasmid.2004.02.003.
27. Oka A, Sugisaki H, Takanami M. 1981. Nucleotide sequence of the kanamycin resistance transposon Tn903. J. Mol. Biol. 147:217-226. http: //dx.doi.org/10.1016/0022-2836(81)90438-1.
28. Stols L, Gu M, Dieckman L, Raffen R, Collart FR, Donnelly MI. 2002. A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. Protein Expr. Purif. 25:8-15. http://dx.doi.org/10.1006/prep.2001.1603.
29. Spyres LM, Qa'Dan M, Meader A, Tomasek JJ, Howard EW, Ballard JD.2001. Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion. Infect. Immun. 69:599-601. http://dx.doi.org/10.1128/IAI.69.1.599-601.2001.
30. Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. 1998. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. U. S. A. 95:13899-13904. http://dx.doi.org/10.1073/pnas.95.23.13899.
31. Danin-Poleg Y, Elgavish S, Raz N, Efimov V, Kashi Y. 2013. Genome sequence of the pathogenic bacterium Vibrio vulnificus biotype 3. Genome Announc. 1:e0013613. http://dx.doi.org/10.1128/genomeA.00136-13.
32. Chatzidaki-Livanis M, Hubbard MA, Gordon K, Harwood VJ, Wright AC. 2006. Genetic distinctions among clinical and environmental strains of Vibrio vulnificus. Appl. Environ. Microbiol. 72:6136-6141. http://dx.doi.org/10.1128/AEM.00341-06.
33. Dolores J, Satchell KJ. 2013. Analysis of Vibrio cholerae genome sequences reveals unique rtxA variants in environmental strains and an rtxA-null mutation in recent Altered El Tor isolates. mBio 4:e00624-00612. http://dx.doi.org/10.1128/mBio.00624-12.
34. Le Roux F, Labreuche Y, Davis BM, Iqbal N, Mangenot S, Goarant C, Mazel D, Waldor MK. 2011. Virulence of an emerging pathogenic lineage of Vibrio nigripulchritudo is dependent on two plasmids. Environ. Microbiol. 13:296-306. http://dx.doi.org/10.1111/j.1462-2920.2010.02329.x.
35. Geissler B, Tungekar R, Satchell KJ. 2010. Identification of a conserved membrane localization domain within numerous large bacterial protein toxins. Proc. Natl. Acad. Sci. U. S. A. 107:5581-5586. http://dx.doi.org/10.1073/pnas.0908700107.
36. Guo Q, Shen Y, Lee YS, Gibbs CS, Mrksich M, Tang WJ. 2005. Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin.EMBOJ. 24:3190-3201. http://dx.doi.org/10.1038 /sj.emboj.7600800.
37. Chase E, Harwood VJ. 2011. Comparison of the effects of environmental parameters on growth rates of Vibrio vulnificus biotypes I, II, and III by culture and quantitative PCR analysis. Appl. Environ. Microbiol. 77: 4200-4207. http://dx.doi.org/10.1128/AEM.00135-11.
38. Lee JH, Kim MW, Kim BS, Kim SM, Lee BC, Kim TS, Choi SH. 2007. Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J. Microbiol. 45:146-152.
39. Kim YR, Lee SE, Kook H, Yeom JA, Na HS, Kim SY, Chung SS, Choy HE, Rhee JH. 2008. Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell. Microbiol. 10:848-862. http: //dx.doi.org/10.1111/j.1462-5822.2007.01088.x.
40. Cordero CL, Kudryashov DS, Reisler E, Satchell KJ. 2006. The actin cross-linking domain of the Vibrio cholerae RTX toxin directly catalyzes the covalent cross-linking of actin. J. Biol. Chem. 281:32366-32374. http: //dx.doi.org/10.1074/jbc.M605275200.
41. Ahrens S, Geissler B, Satchell KJ. 2013. Identification of a His-Asp-Cys catalytic triad essential for function of the Rho inactivation domain (RID) of Vibrio cholerae MARTX toxin. J. Biol. Chem. 288:1397-1408. http://dx.doi.org/10.1074/jbc.M112.396309.
42. Hritonenko V, Mun JJ, Tam C, Simon NC, Barbieri JT, Evans DJ, Fleiszig SM. 2011. Adenylate cyclase activity of Pseudomonas aeruginosa ExoY can mediate bleb-niche formation in epithelial cells and contributes to virulence. Microb. Pathog. 51:305-312. http://dx.doi.org/10.1016/j.micpath.2011.08.001.
43. Confer DL, Eaton JW. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948-950. http://dx.doi.org/10.1126/science.6287574.
44. Leppla SH. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 79:3162-3166. http://dx.doi.org/10.1073/pnas.79.10.3162.
45. Liu M, Alice AF, Naka H, Crosa JH. 2007. The HlyU protein is a positive regulator of rtxA1, a gene responsible for cytotoxicity and virulence in the human pathogen Vibrio vulnificus. Infect. Immun. 75:3282-3289. http: //dx.doi.org/10.1128/IAI.00045-07.
46. Gulig PA, Tucker MS, Thiaville PC, Joseph JL, Brown RN. 2009. USER friendly cloning coupled with chitin-based natural transformation enables rapid mutagenesis of Vibrio vulnificus. Appl. Environ. Microbiol. 75: 4936-4949. http://dx.doi.org/10.1128/AEM.02564-08.
47. Rosche TM, Yano Y, Oliver JD. 2005. A rapid and simple PCR analysis indicates there are two subgroups of Vibrio vulnificus which correlate with clinical or environmental isolation. Microbiol. Immunol. 49:381-389. http://dx.doi.org/10.1111/j.1348-0421.2005.tb03731.x.
48. Cohen AL, Oliver JD, DePaola A, Feil EJ, Boyd EF. 2007. Emergence of a virulent clade of Vibrio vulnificus and correlation with the presence of a 33-kilobase genomic island. Appl. Environ. Microbiol. 73:5553-5565. http://dx.doi.org/10.1128/AEM.00635-07.
49. Shen Y, Lee YS, Soelaiman S, Bergson P, Lu D, Chen A, Beckingham K, Grabarek Z, Mrksich M, Tang WJ. 2002. Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J. 21:6721-6732. http://dx.doi.org/10.1093/emboj/cdf681.
50. Kudryashov DS, Cordero CL, Reisler E, Satchell KJ. 2008. Characterization of the enzymatic activity of the actin cross-linking domain from the Vibrio choleraeMARTXVc toxin. J. Biol. Chem. 283:445-452. http://dx.doi.org/10.1074/jbc.M703910200.
51. Prochazkova K, Satchell KJ. 2008. Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional autoprocessing RTX toxin. J. Biol. Chem. 283:23656-23664. http://dx.doi.org/10.1074/jbc.M803334200.
52. Prochazkova K, Shuvalova LA, Minasov G, Voburka Z, Anderson WF, Satchell KJ. 2009. Structural and molecular mechanism for autoprocessing of MARTX toxin of Vibrio cholerae at multiple sites. J. Biol. Chem. 284:26557-26568. http://dx.doi.org/10.1074/jbc.M109.025510.
53. Ochoa CD, Alexeyev M, Pastukh V, Balczon R, Stevens T. 2012. Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability. J. Biol. Chem. 287:25407-25418. http://dx.doi.org/10.1074/jbc.M111.301440.
54. Lee TH, Kim MH, Lee CS, Lee JH, Rhee JH, Chung KM. 2014. Protection against Vibrio vulnificus infection by active and passive immunization with the C-terminal region of the RtxA1/MARTXVv protein. Vaccine 32:271-276. http://dx.doi.org/10.1016/j.vaccine.2013.11.019.
55. Phillips KE, Schipma MJ, Satchell KJF. 2014. Draft genome sequence of Israeli outbreak-associated Vibrio vulnificus biotype 3 clinical isolate BAA87. Genome Announc. 2:e00032-14. http://dx.doi.org/10.1128 /genomeA.00032-14.